quinazolines has been researched along with Cicatrization in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cáncela-Díez, B; Cuenca-Barrales, C; Galvez-Moreno, M; López-Delgado, D; Ruiz-Villaverde, R | 1 |
Chen, PC; Chu, CY; Shih, YH | 1 |
Galvis-Carvajal, E; Gomer, RH; White, MJ | 1 |
Donovan, JC; Ghazarian, DM; Shaw, JC | 1 |
Anadkat, MJ; Hepper, DM; Wu, P | 1 |
5 other study(ies) available for quinazolines and Cicatrization
Article | Year |
---|---|
Gray-bluish cutaneous pigmentation and ice-pick scars induced by vandetanib therapy.
Topics: Adult; Antineoplastic Agents; Cicatrix; Color; Drug Eruptions; Facial Dermatoses; Female; Humans; Pigmentation Disorders; Piperidines; Quinazolines | 2018 |
Severe refractory scarring alopecia associated with combinational use of ficlatuzumab (AV-299) and gefitinib.
Topics: Aged; Alopecia; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cicatrix; Female; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Quinazolines; Risk Assessment; Severity of Illness Index | 2013 |
A brief exposure to tryptase or thrombin potentiates fibrocyte differentiation in the presence of serum or serum amyloid p.
Topics: Albumins; Cell Differentiation; Cell Movement; Cells, Cultured; Cicatrix; Fibroblasts; Fibrosis; Humans; Interferon-gamma; Lactones; Leukocytes, Mononuclear; Monocytes; Pyridines; Pyrroles; Quinazolines; Receptor, PAR-1; Receptor, PAR-2; Serum Amyloid P-Component; Signal Transduction; Thrombin; Trypsin; Tryptases; Wound Healing | 2015 |
Scarring alopecia associated with use of the epidermal growth factor receptor inhibitor gefitinib.
Topics: Aged; Alopecia; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Cicatrix; Disease Progression; ErbB Receptors; Fatal Outcome; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Male; Quinazolines; Risk Assessment | 2008 |
Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib.
Topics: Aged; Alopecia; Carcinoma, Non-Small-Cell Lung; Cicatrix; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Quinazolines | 2011 |